A promoter polymorphism of the α2-HS glycoprotein gene is associated with its transcriptional activity

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 164-170

  Inoue, Mari ^a   Takata, Hiroshi ^a   Ikeda, Yukio ^a   Suehiro, Tadashi ^a   Inada, Shojiro ^a   Osaki, Fumiaki ^a   Arii, Kaoru ^a   Kumon, Yoshitaka ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

2 Heremans Schmid glycoprotein (AHSG); Fetuin A; Promoter; SNPs

Indexed keywords

CALCIUM; DNA FRAGMENT; FETUIN A; INSULIN RECEPTOR KINASE; PLASMA PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; ALPHA2HS GLYCOPROTEIN; PRIMER DNA; UNCLASSIFIED DRUG;

ADULT; AHSG GENE; ALLELE; ARTICLE; BINDING AFFINITY; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC VARIABILITY; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; ONCOGENE; TUMOR CELL LINE;

ADULT; BLOOD PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HUMANS; LIVER NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 37549039417     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.08.005     Document Type: Article

References (28)

1. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-362
2. Kahn C.R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43 (1994) 1066-1084
3. White M.F. The insulin signalling system and the IRS proteins. Diabetologia 40 Suppl. 2 (1997) S2-S17
4. Pirola L., Johnston A.M., and Van Obberghen E. Modulation of insulin action. Diabetologia 47 (2004) 170-184
5. Brown W.M., Saunders N.R., Mollgard K., and Dziegielewska K.M. Fetuin-an old friend revisited. Bioessays 14 (1992) 749-755
6. Jahnen-Dechent W., Schinke T., Trindl A., Müller-Esterl W., Sablitzky F., Kaiser S., et al. Cloning and targeted deletion of the mouse fetuin gene. J. Biol. Chem. 272 (1997) 31496-31503
7. Price P.A., and Lim J.E. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J. Biol. Chem. 278 (2003) 22144-22152
8. 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 112 (2003) 357-366
9. Heiss A., DuChesne A., Denecke B., Grötzinger J., Yamamoto K., Renne T., et al. Structural basis of calcification inhibition by α2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J. Biol. Chem. 278 (2003) 13333-13341
10. Auberger P., Falquerho L., Contreres J.O., Pages G., Le Cam G., Rossi B., et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58 (1989) 631-640
11. Mathews S.T., Srinivas P.R., Leon M.A., and Grunberger G. Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase. Life Sci. 61 (1997) 1583-1592
12. 2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol. Cell. Endocrinol. 164 (2000) 87-98
13. Mathews S.T., Singh G.P., Ranalletta M., Cintron V.J., Qiang X., Goustin A.S., et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51 (2002) 2450-2458
14. Mathews S.T., Rakhade S., Zhou X., Parker G.C., Coscina D.V., and Grunberger G. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem. Biophys. Res. Commun. 350 (2006) 437-443
15. Mori K., Emoto M., Yokoyama H., Araki T., Teramura M., Koyama H., et al. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29 (2006) 468
16. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 14478-14483
17. Vionnet N., Hani El.-H., Dupont S., Gallina S., Francke S., Dotte S., et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67 (2000) 1470-1480
18. Francke S., Manraj M., Lacquemant C., Lecoeur C., Leprêtre F., Passa P., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10 (2001) 2751-2765
19. Falquerho L., Patey G., Paquereau L., Rossi V., Lahuna O., Szpirer J., et al. Primary structure of the rat gene encoding an inhibitor of the insulin receptor tyrosine kinase. Gene 98 (1991) 209-216
20. 2-HS glycoprotein (AHSG). Gene 196 (1997) 121-125
21. Osawa M., Umetsu K., Ohki T., Nagasawa T., Suzuki T., and Takeichi S. Molecular evidence for human alpha2-HS glycoprotein (AHSG) polymorphism. Hum. Genet. 99 (1997) 18-21
22. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
23. 2-Heremans-Schmid glycoprotein gene polymorphisms are associated with adipocyte insulin action. Diabetologia 47 (2004) 1974-1979
24. Lavebratt C., Dungner E., and Hoffstedt J. Polymorphism of the AHSG gene is associated with increased adipocyte β2-adrenoceptor function. J. Lipid Res. 46 (2005) 2278-2281
25. 2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 54 (2005) 2477-2481
26. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
27. Bushel P., Kim J.H., Chang W., Catino J.J., Ruley H.E., and Kumar C.C. Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells. Oncogene 10 (1995) 1361-1370
28. Schreiber M., Kolbus A., Piu F., Szabowski A., Möhle-Steinlein U., Tian J., et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 13 (1999) 607-619